Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multicenter Prospective Study”

4,514 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 4,514 results

Not applicableUnknownNCT03862729
What this trial is testing

Risk Stratification and Minimally Invasive Surgery in Acute ICH Patients

Who this might be right for
Spontaneous Intracerebral Hemorrhage
First Affiliated Hospital of Fujian Medical University 1,300
Large-scale testing (Phase 3)Looking for participantsNCT06345365
What this trial is testing

MA+AZA Regimen for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukaemia
Zhongnan Hospital 154
Not applicableStudy completedNCT02657265
What this trial is testing

SpineJack® Versus Conservative Treatment Study (SPICO Study)

Who this might be right for
Spinal FracturesVertebral Compression FracturesBack Injuries+1 more
Vexim SA 100
Testing effectiveness (Phase 2)Study completedNCT03539302
What this trial is testing

INhalation of Flecainide to Convert Recent Onset SympTomatic Atrial Fibrillation to siNus rhyThm (INSTANT)

Who this might be right for
Paroxysmal Atrial Fibrillation (PAF)
InCarda Therapeutics, Inc. 176
Large-scale testing (Phase 3)Looking for participantsNCT06664775
What this trial is testing

Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery

Who this might be right for
Hemorrhage
Corza Medical GmbH 116
Not applicableNot Yet RecruitingNCT07161167
What this trial is testing

Changes in Body Composition of Patients With Obesity Related Tumors and Their Impact on Clinical Outcomes: a Multicenter Prospective Cohort Study

Who this might be right for
Obesity Rekated CancerBody Composition ChangesSurvival+1 more
Peking Union Medical College Hospital 6,743
Not applicableNot Yet RecruitingNCT07111572
What this trial is testing

Fecal biOmarker Response Evaluation for Super-Early Efficacy in Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)Fecal CalprotetinFIT
Qilu Hospital of Shandong University 100
Not applicableUnknownNCT04273477
What this trial is testing

Radiomics-based Artificial Intelligence System to Predict Neoadjuvant Treatment Response in Rectal Cancer

Who this might be right for
Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University 100
Not applicableStudy completedNCT02151812
What this trial is testing

Comparison of Agent™ and SeQuent® Please Paclitaxel Coated Balloon Catheters in Coronary In-stent Restenosis (AGENT-ISR)

Who this might be right for
Coronary Artery DiseaseCoronary RestenosisCoronary Atherosclerosis+1 more
Hemoteq AG 123
Large-scale testing (Phase 3)Looking for participantsNCT06791512
What this trial is testing

MFOLFOX6 + Bevacizumab + PD-1 Monoclonal Antibody Vs. mFOLFOX6 in Locally Advanced pMMR/MSS CRC

Who this might be right for
Colorectal Cancer (CRC)pMMR/MSS Adenocarcinoma of the Colon or Rectum
Jun Huang 166
Not applicableLooking for participantsNCT04957901
What this trial is testing

The Value of Monitoring Circulating Cell DNA (ctDNA) in Pediatric Lymphoma: A Prospective, Multicenter Clinical Study

Who this might be right for
Lymphoma
Sun Yat-sen University 60
Not applicableNot Yet RecruitingNCT06868030
What this trial is testing

Efficacy and Safety of Conventional Symptomatic Drugs Combined with Lencanizumab in the Treatment of Early Alzheimer's Disease: a Multicenter, Prospective, Observational Study

Who this might be right for
Alzheimer's DiseaseMCI-AD, Early Stage Alzheimer's Disease
First Hospital of China Medical University 120
Testing effectiveness (Phase 2)Study completedNCT03844945
What this trial is testing

Efficacy and Systemic Safety of Netarsudil 0.01%, 0.02%, 0.04% Relative to Placebo in Subjects With Open-angle Glaucoma or Ocular Hypertension in Japan

Who this might be right for
Open Angle GlaucomaOcular Hypertension
Aerie Pharmaceuticals 215
Large-scale testing (Phase 3)Study completedNCT00389987
What this trial is testing

Ertapenem Sodium vs. Piperacillin/Tazobactam in the Treatment of Complicated Intra-Abdominal Infections (0826-037)

Who this might be right for
Complicated Intra-Abdominal Infections
Merck Sharp & Dohme LLC 300
Not applicableStudy completedNCT06792708
What this trial is testing

Observational Study of LUMRYZ in Narcolepsy

Who this might be right for
Narcolepsy
Avadel 71
Not applicableStudy completedNCT06870071
What this trial is testing

Effect of Quadro-Iliac Plane Block on Recovery After Total Hip Arthroplasty

Who this might be right for
Postoperative Pain
Konya City Hospital 64
Not applicableLooking for participantsNCT06422871
What this trial is testing

PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis

Who this might be right for
End Stage Renal DiseaseHemodialysis Access Failure
Merit Medical Systems, Inc. 100
Not applicableLooking for participantsNCT07455136
What this trial is testing

Develop a Blood-based Test for Aiding the Diagnosis/Prognosis of Traumatic Brain Injury in Adults and for Monitoring the Development of Secondary Events in Patients Diagnosed With Traumatic Brain Injury

Who this might be right for
Traumatic Brain Injury
Hoffmann-La Roche 2,000
Not applicableStudy completedNCT03783871
What this trial is testing

NeuWave Microwave Ablation HCC China Study

Who this might be right for
Liver TumorHepatocellular Carcinoma
Ethicon, Inc. 135
Testing effectiveness (Phase 2)Study completedNCT02968563
What this trial is testing

Study to Evaluate the Safety and Efficacy of the Combination of Tirabrutinib and Idelalisib With and Without Obinutuzumab in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia
Gilead Sciences 35
Load More Results